Cost Effectiveness of Renal Denervation Therapy for the Treatment of Resistant Hypertension in the Netherlands

Value in Health- United Kingdom

doi 10.1016/j.jval.2014.08.1445

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

A Controlled Trial of Renal Denervation for Resistant Hypertension

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2014English

Renal Denervation for Resistant Hypertension—the Symplicity HTN-1 Study

The Lancet
Medicine
2014English

Renal Denervation in the Treatment of Resistant Hypertension: Results of a One-Year Observational Study

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2015English

Meta-Analysis of Randomized Controlled Trials of Renal Denervation in Treatment-Resistant Hypertension

Blood Pressure
Internal MedicineMedicineCardiovascular MedicineCardiology
2015English

Renal Denervation in Patient With Resistant Hypertension: A Case Report

Srce i krvni sudovi
2012English

Expanding the Targets of Renal Sympathetic Denervation: From Resistant Hypertension to Atrial Fibrillation

Journal of Hypertension- Open Access
2013English

Pnd64 - Cost-Effectiveness of Cladribine Tablets for Treatment of RRMS in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

The Cost Implications of Renal Denervation Therapy at the Hospital Level in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy